benzoylhydrazide HDAC inhibitors (University of Florida)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebenzoylhydrazide HDAC inhibitors (University of Florida)
Drug Alias Nameclass I-specific HDAC inhibitors (University of Florida)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsNerve DegenerationMetabolic DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Florida
Active IndicationsN/A
Inactive IndicationsNerve DegenerationMetabolic DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A